1. American Heart Association . Cardiovascular Disease: A Costly Burden for America. Projections Through 2035. American Heart Association; 2017.
Google Scholar2. Virani, SS, Alonso, A, Aparicio, HJ, et al. Heart Disease and Stroke Statistics-2021 update: a report from the American Heart Association. Circulation. 2021;143(8):e254. doi:10.1161/cir.0000000000000950.
Google Scholar | Crossref | Medline3. Geltman, EM, Ehsani, AA, Campbell, MK, Schechtman, K, Roberts, R, Sobel, BE. The influence of location and extent of myocardial infarction on long-term ventricular dysrhythmia and mortality. Circulation. 1979;60(4):805.
Google Scholar | Crossref | Medline4. Kelle, S, Roes, SD, Klein, C, et al. Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging. J Am Coll Cardiol. 2009;54(19):1770. doi:10.1016/j.jacc.2009.07.027
Google Scholar | Crossref | Medline5. Stone, GW, Selker, HP, Thiele, H, et al. Relationship between infarct size and outcomes following primary PCI patient-level analysis from 10 randomized trials. J Am Coll Cardiol. 2016;67(14):1674. doi:10.1016/j.jacc.2016.01.069
Google Scholar | Crossref | Medline6. Francone, M, Bucciarelli-Ducci, C, Carbone, I, et al. Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction insight from cardiovascular magnetic resonance. J Am Coll Cardiol. 2009;54(23):2145. doi:10.1016/j.jacc.2009.08.024
Google Scholar | Crossref | Medline | ISI7. Ibanez, B, Heusch, G, Ovize, M, Werf FVd . Evolving therapies for myocardial ischemia/reperfusion injury. J Am Coll Cardiol. 2015;65(14):1455. doi:10.1016/j.jacc.2015.02.032
Google Scholar | Crossref8. Boersma, H, Califf, R, Collins, R, Deckers, JW, Simoons, ML. Selection of reperfusion therapy for individual patients with evolving myocardial infarction. Eur Heart J. 1997;18(9):1371–1381. doi:10.1093/oxfordjournals.eurheartj.a015461
Google Scholar | Crossref | Medline9. Jhund, PS, McMurray, JJV. Heart failure after acute myocardial infarction: a lost battle in the war on heart failure? Circulation. 2008;118(20):2019. doi:10.1161/circulationaha.108.813493
Google Scholar | Crossref | Medline10. Cahill, TJ, Kharbanda, RK. Heart failure after myocardial infarction in the era of primary percutaneous coronary intervention: mechanisms, incidence and identification of patients at risk. World J Cardiol. 2017;9(5):407–415. doi:10.4330/wjc.v9.i5.407
Google Scholar | Crossref | Medline11. McNamara, RL, Wang, Y, Herrin, J, et al. Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2006;47(11):2180–2186. doi:10.1016/j.jacc.2005.12.072
Google Scholar | Crossref | Medline | ISI12. Berger, PB, Ellis, SG, Holmes, DR, et al. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction. Circulation. 1999;100(1):14–20. doi:10.1161/01.cir.100.1.14
Google Scholar | Crossref | Medline | ISI13. O’Gara, PT., Kushner, FG, Ascheim, DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary. Circulation. 2013;127(4):529–555. doi:10.1161/cir.0b013e3182742c84
Google Scholar | Crossref | Medline | ISI14. Ibanez, B, James, S, Agewall, S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. The task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2017;39(2):119–177. doi:10.1093/eurheartj/ehx393
Google Scholar | Crossref15. Hausenloy, DJ, Yellon, DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest. 2013;123(1):92. doi:10.1172/jci62874
Google Scholar | Crossref | Medline | ISI16. Murry, CE, Jennings, RB, Reimer, KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74(5):1124. doi:10.1161/01.cir.74.5.1124
Google Scholar | Crossref | Medline | ISI17. Speechly-Dick, M, Baxter, GF, Yellon, DM. Ischaemic preconditioning protects hypertrophied myocardium. Cardiovasc Res. 1994;28(7):1025. doi:10.1093/cvr/28.7.1025
Google Scholar | Crossref | Medline | ISI18. Dong, Y, Undyala, VV, Gottlieb, RA, Mentzer, RM, Przyklenk, K. Review: autophagy: definition, molecular machinery, and potential role in myocardial ischemia-reperfusion injury. J Cardiovasc Pharmacol Ther. 2010;15(3):220–230. doi:10.1177/1074248410370327
Google Scholar | SAGE Journals | ISI19. Garcia-Dorado, D, Piper, HM. Postconditioning: reperfusion of “reperfusion injury” after hibernation. Cardiovasc Res. 2006;69(1):1–3. doi:S0008-6363(05)00524-9
Google Scholar | Crossref | Medline20. Longacre, LS, Kloner, RA, Arai, AE, et al. New horizons in cardioprotection: recommendations from the 2010 national heart, lung, and blood institute workshop. Circulation. 2011;124(10):1172–1179.
Google Scholar | Crossref | Medline21. Hausenloy, DJ, Garcia-Dorado, D, Bøtker, HE, et al. Novel targets and future strategies for acute cardioprotection: position paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart. Cardiovasc Res. 2017;113(6):564–585.
Google Scholar | Crossref | Medline22. Fröhlich, GM, Meier, P, White, SK, Yellon, DM, Hausenloy, DJ. Myocardial reperfusion injury: looking beyond primary PCI. Eur Heart J. 2013;34(23):1714. doi:10.1093/eurheartj/eht090
Google Scholar | Crossref | Medline23. Zhao, Z, Corvera, JS, Halkos, ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285(2): H579. doi:10.1152/ajpheart.01064.2002
Google Scholar | Crossref | Medline | ISI24. Engstrøm, T, Kelbæk, H, Helqvist, S, et al. Effect of ischemic postconditioning during primary percutaneous coronary intervention for patients with ST-segment elevation myocardial infarction: a randomized clinical trial. JAMA Cardiology. 2017;2(5):490. doi:10.1001/jamacardio.2017.0022.
Google Scholar | Crossref | Medline25. Spears, JR, Prcevski, P, Jiang, A, Brereton, GJ, Heide, RV. Intracoronary aqueous oxygen perfusion, performed 24 h after the onset of postinfarction reperfusion, experimentally reduces infarct size and improves left ventricular function. Int J Cardiol. 2006;113(3):371–375. doi: 10.1016/j.ijcard.2005.11.099
Google Scholar | Crossref | Medline26. Heusch, G . Myocardial ischaemia–reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol. 2020;17(12):773–789. doi:10.1038/s41569-020-0403-y
Google Scholar | Crossref | Medline27. Caricati-Neto, A, Errante, PR, Menezes-Rodrigues, F. Recent advances in pharmacological and non-pharmacological strategies of cardioprotection. Int J Mol Sci. 2019;20(16):4002. doi:10.3390/ijms20164002
Google Scholar | Crossref28. Kalogeris, T, Baines, CP, Krenz, M, Korthuis, RJ. Ischemia/reperfusion. Comprehensive Physiol. 2017;7(1):113–170. doi:10.1002/cphy.c160006
Google Scholar29. Gottlieb, RA . Cell death pathways in acute ischemia/reperfusion injury. J Cardiovasc Pharmacol Ther. 2011;16(3-4):233–238. doi:10.1177/1074248411409581
Google Scholar | SAGE Journals | ISI30. Wu, MY, Yiang, GT, Liao, WT, et al. Current mechanistic concepts in ischemia and reperfusion injury. Cell Physiol Biochem. 2018;46(4):1650–1667. doi:10.1159/000489241
Google Scholar | Crossref | Medline31. Kloner, RA, Ganote, CE, Jennings, RB. The “no-reflow” phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 1974;54(6):1496–1508. doi:10.1172/JCI107898
Google Scholar | Crossref | Medline | ISI32. Engler, RL, Dahlgren, MD, Morris, DD, Peterson, MA, Schmid-Schonbein, GW. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol. 1986;251(2 Pt 2):314. doi:10.1152/ajpheart.1986.251.2.H314
Google Scholar33. Reffelmann, T, Kloner, RA. The “no-reflow” phenomenon: basic science and clinical correlates. Heart. 2002;87(2):162–168. doi:10.1136/heart.87.2.162
Google Scholar | Crossref | Medline | ISI34. Rezkalla, SH, Kloner, RA. No-reflow phenomenon. Circulation. 2002;105(5):656–662. doi:10.1161/hc0502.102867
Google Scholar | Crossref | Medline | ISI35. Dirksen, MT, Laarman, GJ, Simoons, ML, Duncker, DJ. Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies. Cardiovasc Res. 2007;74(3):343–355. doi:S0008-6363(07)00021-1
Google Scholar | Crossref | Medline36. Kloner, RA . No-reflow phenomenon: maintaining vascular integrity. J Cardiovasc Pharmacol Ther. 2011;16(3-4):244–250. doi:10.1177/1074248411405990
Google Scholar | SAGE Journals | ISI37. Kloner, RA, King, KS, Harrington, MG. No-reflow phenomenon in the heart and brain. Am J Physiol Heart Circ Physiol. 2018;315(3):H550–H562. doi:10.1152/ajpheart.00183.2018
Google Scholar | Crossref | Medline38. Kloner, RA, Rude, RE, Carlson, N, Maroko, PR, DeBoer, LW, Braunwald, E. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first? Circulation. 1980;62(5):945–952. doi:10.1161/01.cir.62.5.945
Google Scholar | Crossref | Medline | ISI39. Kloner, RA, Alker, KJ. The effect of streptokinase on intramyocardial hemorrhage, infarct size, and the no-reflow phenomenon during coronary reperfusion. Circulation. 1984;70(3):513–521. doi:10.1161/01.cir.70.3.513
Google Scholar | Crossref | Medline40. Lelovas, PP, Kostomitsopoulos, NG, Xanthos, TT. A comparative anatomic and physiologic overview of the porcine heart. J Am Assoc Lab Animal Sc. 2014;53(5):432.
Google Scholar | Medline | ISI41. Reffelmann, T, Kloner, RA. Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit. Am J Physiol Heart Circ Physiol. 2002;283(3):1099. doi:10.1152/ajpheart.00270.2002
Google Scholar | Crossref | Medline42. Hale, SL, Kloner, RA. Dabigatran treatment: effects on infarct size and the no-reflow phenomenon in a model of acute myocardial ischemia/reperfusion. J Thromb Thrombolysis. 2015;39(1):50–54. doi:10.1007/s11239-014-1098-x
Google Scholar | Crossref | Medline43. Kloner, RA . The importance of no-reflow/microvascular obstruction in the STEMI patient. Eur Heart J. 2017;38(47):3511–3513. doi:10.1093/eurheartj/ehx288
Google Scholar | Crossref | Medline44. Topol, EJ, Yadav, JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation. 2000;101(5):570–580. doi:10.1161/01.cir.101.5.570
Google Scholar | Crossref | Medline45. Tanaka, A, Kawarabayashi, T, Nishibori, Y, et al. No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction. Circulation. 2002;105(18):2148–2152. doi:10.1161/01.cir.0000015697.59592.07
Google Scholar | Crossref | Medline | ISI46. Ito, H, Maruyama, A, Iwakura, K, et al. Clinical implications of the ‘no reflow’ phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation. 1996;93(2):223–228. doi:10.1161/01.cir.93.2.223
Google Scholar | Crossref | Medline | ISI47. Romson, JL, Hook, BG, Kunkel, SL, Abrams, GD, Schork, MA, Lucchesi, BR. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation. 1983;67(5):1016–1023. doi:10.1161/01.cir.67.5.1016
Google Scholar | Crossref | Medline48. Carden, DL, Granger, DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol. 2000;190(3):255–266. doi:10.1002/(SICI)1096-9896(200002)190:33.0.CO;2-6
Goog